Net Cash Provided by (Used in) Operating Activities |
1.14M |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-1.28M |
USD |
-117% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-704K |
USD |
+28.7% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
13.6M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-838K |
USD |
+28.8% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
28M |
USD |
+22% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
2.9M |
USD |
+6.2% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
21.5M |
USD |
+14.4% |
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
-2.68M |
USD |
+11.1% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Current Income Tax Expense (Benefit) |
150K |
USD |
-7.41% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
306M |
USD |
0% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
4.03M |
USD |
+1.62% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
2.3M |
USD |
0% |
Q2 2024 |
Q2 2024 |
Share-based Payment Arrangement, Expense |
0 |
USD |
-100% |
Q4 2023 |
FY 2023 |
Interest Expense |
18.2M |
USD |
+17.3% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |